StephaniePMathewsMD
Pathology • Chapel Hill, NCHematopathology, Anatomic Pathology, Clinical Pathology
Physician
Dr. Mathews is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
143 W Franklin St
Ste 600
Chapel Hill, NC 27516Phone+1 919-966-4081Fax+1 919-843-6949
Education & Training
University of North Carolina HospitalsFellowship, Hematopathology, 2009 - 2010- University of North Carolina HospitalsResidency, Pathology-Anatomic and Clinical, 2005 - 2009
University of South Carolina School of MedicineClass of 2005
Certifications & Licensure
NC State Medical License 2005 - 2025- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- Novel use of Siltuximab in a patient with VEXAS Syndrome.Beatriz Cáceres-Nazario, Joshua Rivenbark, Manish K Saha, Stephanie Mathews, Samuel M Rubinstein
Annals of Hematology. 2024-10-17 - 26 citationsEarly Relapse Identifies MCL patients with Inferior Survival after Intensive or Less Intensive Frontline Therapy.David A. Bond, Jeffrey M. Switchenko, Diego Villa, Kami J. Maddocks, Michael C. Churnetski
Blood Advances. 2021-09-13 - 13 citationsMulti-Center Analysis of Practice Patterns and Outcomes of Younger and Older Patients with Mantle Cell Lymphoma in the Rituximab Era.Reem Karmali, Jeffrey M. Switchenko, Subir Goyal, Krithika Shanmugasundaram, Michael C. Churnetski
American Journal of Hematology. 2021-07-29
Abstracts/Posters
- Outcomes Following Early Relapse in Patients with Mantle Cell LymphomaStephanie Mathews, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Clinical Trial Participation Is Associated with Improved Overall Survival in Newly Diagnosed Patients with Mantle Cell LymphomaStephanie Mathews, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Short Time to Treatment Is Associated with Inferior Survival in Newly Diagnosed Patients with Mantle Cell LymphomaStephanie Mathews, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
